These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Pathology Consultation on the Diagnosis and Treatment of Thrombotic Microangiopathies (TMAs). Williams LA; Marques MB; Am J Clin Pathol; 2016 Feb; 145(2):158-65. PubMed ID: 27124904 [TBL] [Abstract][Full Text] [Related]
11. Impact of a multidisciplinary team for the management of thrombotic microangiopathy. Uriol Rivera MG; Cabello Pelegrin S; Ballester Ruiz C; López Andrade B; Lumbreras J; Obrador Mulet A; Perez Montaña A; Ferreruela Serlavos M; Ayestarán Rota JI; Ferrer Balaguer J; Delgado Sanchez O; Pallares Ferreres L; Mas Bonet A; Picado Valles MJ; de Gopegui Valero RMR PLoS One; 2018; 13(11):e0206558. PubMed ID: 30388144 [TBL] [Abstract][Full Text] [Related]
12. Thrombotic microangiopathy in children. Palma LMP; Vaisbich-Guimarães MH; Sridharan M; Tran CL; Sethi S Pediatr Nephrol; 2022 Sep; 37(9):1967-1980. PubMed ID: 35041041 [TBL] [Abstract][Full Text] [Related]
13. [Diagnosis and treatment of microangiopathic hemolytic anemia]. Morishita E Rinsho Ketsueki; 2015 Jul; 56(7):795-806. PubMed ID: 26251142 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of patients with microangiopathic hemolytic anemia and thrombocytopenia. George JN; Charania RS Semin Thromb Hemost; 2013 Mar; 39(2):153-60. PubMed ID: 23390027 [TBL] [Abstract][Full Text] [Related]
15. Thrombotic microangiopathy with targeted cancer agents. Blake-Haskins JA; Lechleider RJ; Kreitman RJ Clin Cancer Res; 2011 Sep; 17(18):5858-66. PubMed ID: 21813634 [TBL] [Abstract][Full Text] [Related]
16. Making the Correct Diagnosis in Thrombotic Microangiopathy: A Narrative Review. McFarlane PA; Bitzan M; Broome C; Baran D; Garland J; Girard LP; Grewal K; Lapeyraque AL; Patriquin CJ; Pavenski K; Licht C Can J Kidney Health Dis; 2021; 8():20543581211008707. PubMed ID: 33996107 [TBL] [Abstract][Full Text] [Related]
17. [Diagnostic and therapeutic guidelines of thrombotic microangiopathies of the Spanish Apheresis Group]. Contreras E; de la Rubia J; Del Río-Garma J; Díaz-Ricart M; García-Gala JM; Lozano M; Med Clin (Barc); 2015 Apr; 144(7):331.e1-331.e13. PubMed ID: 25433791 [TBL] [Abstract][Full Text] [Related]
18. [The revolution of monoclonal antibodies in the treatment of thrombotic microangiopathy]. Sauvètre G; Grange S; Froissart A; Veyradier A; Coppo P; Benhamou Y Rev Med Interne; 2015 May; 36(5):328-38. PubMed ID: 25547956 [TBL] [Abstract][Full Text] [Related]
19. Thrombotic microangiopathy: current knowledge and outcomes with plasma exchange. Clark WF Semin Dial; 2012; 25(2):214-9. PubMed ID: 22309967 [TBL] [Abstract][Full Text] [Related]
20. Thrombocytopenia in hospitalized patients: approach to the patient with thrombotic microangiopathy. Scully M Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):651-659. PubMed ID: 29222317 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]